Teva refinances RCF, reducing it to $2.3bn
Teva Pharmaceutical Industries has completed a $2.3bn loan syndication, to replace a $3bn revolving credit facility.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: